Test Price
2,800 AED✅ Home Collection Available
PROM1 Gene Cone‑Rod Dystrophy Type 12 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Next‑Generation Sequencing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by Consultant Medical Geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The PROM1 gene cone‑rod dystrophy type 12 (CORD12) Genetic Test detects pathogenic variants in the PROM1 gene, confirming the diagnosis of autosomal recessive cone‑rod dystrophy with high precision. This next‑generation sequencing test offers 99.9% analytical sensitivity, aiding in early intervention and family planning in full compliance with UAE genetic testing regulations and Federal Decree-Law No. 4 of 2016 on Medical Liability.
| Feature | Our NGS Test | Conventional Sanger Panel |
|---|---|---|
| Method | Next‑Generation Sequencing (NGS) | Sanger Sequencing (limited exons) |
| Turnaround Time | 3 to 4 weeks | 4 to 6 weeks |
| PROM1 Gene Coverage | Full gene (all exons & splice sites) | Selected hotspots only |
| ISO 9001:2015 Accreditation | Yes (Cert: INT/EGQ/2509DA/3139) | May vary |
| Genetic Counselling Included | Yes (mandatory pre‑test session) | Often optional |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist, I recognise that genetic testing can evoke significant anxiety. A positive PROM1 result must always be interpreted alongside a comprehensive ophthalmologic evaluation and detailed family history — it is not a standalone prognostic tool. Negative results do not exclude other genetic or acquired retinal conditions, and ongoing ophthalmologic surveillance remains essential.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice
This genetic test is a diagnostic tool and does not replace ongoing clinical management by your ophthalmologist or geneticist. All prescribed treatments, therapies, or supplements must be continued unless explicitly advised otherwise by your treating physician. Do not alter any medication regimen based solely on genetic test results.
Exclusion Criteria & Emergency Red Flags
- Inability to provide informed consent (minors require parental consent per UAE Federal Law No. 2 of 2019).
- Active systemic infection or recent blood transfusion that may compromise DNA quality.
- Refusal to attend mandatory genetic counselling session.
Emergency Red Flags:
This is a diagnostic genetic test; it does not treat acute conditions. Seek immediate medical attention if you experience sudden vision loss, severe eye pain, or new floaters after sample collection (rare occurrence).
Patient FAQ & Clinical Guidance
1. What is the purpose of the PROM1 cone‑rod dystrophy genetic test?
This test detects disease‑causing mutations in the PROM1 gene to confirm a diagnosis of cone‑rod dystrophy type 12 and guide prognosis. It provides a definitive molecular diagnosis, helping ophthalmologists and geneticists tailor long‑term vision management and family planning advice.
2. How is the sample collected and what is the turnaround time?
A peripheral whole blood sample or dried blood spot on an FTA card is collected. Our VIP Mobile Phlebotomy service uses temperature‑controlled cold‑chain logistics to ensure DNA stability. Results are available within 3 to 4 weeks from sample receipt at the laboratory.
3. Are there legal or privacy concerns in the UAE regarding genetic testing?
All genetic testing is conducted in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genomic data is handled in a DHA‑licensed facility with strict confidentiality protocols, and you retain full control over your information.
4. Can this test be performed at home through mobile phlebotomy?
Yes. For peripheral whole blood or dried blood spot specimens, our VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection service is available daily from 8 AM to 11 PM. A certified phlebotomist visits your residence or office within Dubai to collect the sample.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: This genetic test adheres to Federal Decree-Law No. 4 of 2016 on Medical Liability for clinical safety and informed consent; Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for genomic data privacy; and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields for digital health records. Our laboratory holds ISO 9001:2015 Certification (INT/EGQ/2509DA/3139) and operates under DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | PROM1 Gene Cone‑Rod Dystrophy Type 12 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Peripheral Whole Blood or Dried Blood Spot (DBS) on FTA Card |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Gene Sequencing (all exons & splice sites) |
| ICD-10-CM Code | H35.54 (Cone‑rod dystrophy) |
| LOINC Code | 66916-3 (Genetic analysis of a specific gene using targeted mutation analysis method, Blood or Tissue) |
| DHA Facility License & Address | DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians